Not-for-Profit Hospitals Cost-Cutting Isn’t Keeping Up with Revenue Decline
Modern Healthcare reports that not-for-profit hospitals "have begun to rein in expenses, but it's not happening as fast as revenue growth is dropping." The article notes the efforts hospitals have engaged to reduce supply costs,
EU aims to abolish planned obsolescence
The European Union is looking into “planned obsolescence.” Specifically, the European Parliament is asking the European Commission to “create a clear definition of the term ‘planned obsolescence,’ and to develop a system to track that
Yale surgeons make sustainability and wellness a focus in their workplace
Yale Sustainability reports on how their surgeons make sustainability and wellness a focus in their workplace. Yale surgeons have a positive impact on individual lives every day, but now they are working towards a positive
Hospitals Launch Their Own Competition to Generics Drugs – Implications for Devices
In the last month, the healthcare trade press focused on an ongoing spat between the drug industry and America’s hospitals over who is to blame for rising costs. As part of this, and of particular interest
Dan Vukelich, President and CEO of AMDR, The Washington Based Association for Medical Device Reprocessing Companies, Interview with French Federal of Private Hospitals (AMDR English Translation)
This article was originally posted in the French Federation of private hospitals newsletter. The original version can be found in French at this link. What is the reprocessing regulation abroad? The new European Medical Devices Regulation, adopted
Restrictive Innovation: How Medical Device Manufacturers Confound Clinical Excellence
An Industry Example: Medical Device Reprocessing Reprocessing had a huge mention in Forbes. The unnecessary and rapid launch of “new and improved” products designed to confound commoditization places constant pressure on hospitals to spend money on